4 ms·
Not really, as the trials were done on representative samples of the general population, we know at least we are not underdosing anyone wrt those metrics. Redu
by acituan 5y ago
Not really, as the trials were done on representative samples of the general population, we know at least we are not underdosing anyone wrt those metrics.
Reducing the dose as much as possible would be minimizing it.
- _Microft 5y agoMost likely we are just looking at this from two different points of view because in my opinion minimizing use of a resource is a form of optimization?
- acituan 5y agoYou're absolutely right, one could optimize with respect to any of the infinite attributes a thing has. We could have optimized for the shininess of the doses, or how good they smelled, and those would be ridiculously irrelevant properties to optimize for. The question is how relevant the use of which resources as a metric in comparison to people not getting sick? Does it even take more resources to distribute a 10x dose vaccine vs x? Is the production of the active ingredient a linear contributor to the overall cost function, which probably is dominated by a lot of the constant costs? We're not talking about 250mg vs 500mg tylenol after all.